|
109
|
348
|
3fskA |
P38 kinase crystal structure in complex with ro6257 |
|
73
|
302
|
3fpmA |
Crystal structure of a squarate inhibitor bound to mapkap kinase-2 |
|
95
|
349
|
3gb2A |
Gsk3beta inhibitor complex |
|
96
|
299
|
3fxxA |
Human epha3 kinase and juxtamembrane region bound to substrate kqwdnye[ptyr]iw |
|
106
|
334
|
3fwqA |
Inactive conformation of human protein kinase ck2 catalytic subunit |
|
92
|
277
|
3fqsA |
Crystal structure of spleen tyrosine kinase complexed with r406 |
|
81
|
278
|
3g6gA |
Equally potent inhibition of c-src and abl by compounds that recognize inactive kinase conformations |
|
92
|
290
|
3fupA |
Crystal structures of jak1 and jak2 inhibitor complexes |
|
104
|
332
|
3g0eA |
Kit kinase domain in complex with sunitinib |
|
74
|
273
|
3fzrA |
Crystal structure of pyk2 complexed with pf-431396 |
|
90
|
298
|
3fy2A |
Human epha3 kinase and juxtamembrane region bound to substrate kqwdnyefiw |
|
108
|
348
|
3fsfA |
P38 kinase crystal structure in complex with 3-(2,6-dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one |
|
80
|
277
|
3g5dA |
Kinase domain of csrc in complex with dasatinib |
|
85
|
307
|
3g0fA |
Kit kinase domain mutant d816h in complex with sunitinib |
|
88
|
317
|
3fxwA |
High resolution crystal structure of mitogen-activated protein kinase-activated protein kinase 3/inhibitor 2 complex |
|
99
|
346
|
3fv8A |
Jnk3 bound to piperazine amide inhibitor, sr2774. |
|
78
|
274
|
3fzpA |
Crystal structure of pyk2 complexed with atpgs |
|
59
|
320
|
3fyjX |
Crystal structure of an optimzied benzothiophene inhibitor bound to mapkap kinase-2 (mk-2) |
|
62
|
291
|
3g33A |
Crystal structure of cdk4/cyclin d3 |
|
80
|
271
|
3fzsA |
Crystal structure of pyk2 complexed with birb796 |
|
85
|
271
|
3fztA |
Crystal structure of pyk2 complexed with pf-4618433 |
|
82
|
300
|
3g51A |
Structural diversity of the active conformation of the n-terminal kinase domain of p90 ribosomal s6 kinase 2 |
|
123
|
377
|
3g15A |
Crystal structure of human choline kinase alpha in complex with hemicholinium-3 and adp |
|
81
|
272
|
3fzoA |
Crystal structure of pyk2-apo, proline-rich tyrosine kinase |
|
81
|
298
|
3gc0A |
Structure of the cmgc cdk kinase from giardia lamblia in complex with amp |
|
102
|
356
|
3g9nA |
Jnk3 bound to (z)-1-((6-fluoro-4h-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-phenylindolin-2-one |
|
81
|
298
|
3fz1A |
Crystal structure of a benzthiophene inhibitor bound to human cyclin-dependent kinase-2 (cdk-2) |
|
104
|
348
|
3fc1X |
Crystal structure of p38 kinase bound to pyrimido-pyridazinone inhibitor |
|
98
|
349
|
3f88A |
Glycogen synthase kinase 3beta inhibitor complex |
|
113
|
349
|
3fmhA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-8-methyl-2-((r)-1-methyl-2-tetrazol-2-yl-ethylamino)-8h-pyrido[2,3-d]pyrimidin-7-one |
|
101
|
357
|
3fi3A |
Crystal structure of jnk3 with indazole inhibitor, sr-3737 |
|
84
|
269
|
3fdnA |
Structure-based drug design of novel aurora kinase a inhibitors: structure basis for potency and specificity |
|
81
|
279
|
3f6xA |
C-src kinase domain in complex with small molecule inhibitor |
|
82
|
277
|
3f3uA |
Kinase domain of csrc in complex with inhibitor rl37 (type iii) |
|
108
|
348
|
3fkoA |
P38 kinase crystal structure in complex with ro3668 |
|
105
|
349
|
3fi4A |
P38 kinase crystal structure in complex with ro4499 |
|
81
|
306
|
3f82A |
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
|
110
|
349
|
3fmkA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-8-methyl-2-((s)-1-methyl-2-tetrazol-2-yl-ethylamino)-8h-pyrido[2,3-d]pyrimidin-7-one |
|
78
|
285
|
3f69A |
Crystal structure of the mycobacterium tuberculosis pknb mutant kinase domain in complex with kt5720 |
|
85
|
307
|
3f5pA |
Complex structure of insulin-like growth factor receptor and 3-cyanoquinoline inhibitor |
|
108
|
336
|
3fjqE |
Crystal structure of camp-dependent protein kinase catalytic subunit alpha in complex with peptide inhibitor pki alpha (6-25) |
|
93
|
298
|
3f66A |
Human c-met kinase in complex with quinoxaline inhibitor |
|
110
|
349
|
3flsA |
P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-((r)-2-methanesulfonyl-1-methyl-ethylamino)-8-methyl-8h-pyrido[2,3-d]pyrimidin-7-one |
|
124
|
375
|
3f2rA |
Crystal structure of human choline kinase alpha in complex with hemicholinium-3 |
|
112
|
349
|
3fklA |
P38 kinase crystal structure in complex with ro9552 |
|
107
|
338
|
3fhiA |
Crystal structure of a complex between the catalytic and regulatory (ri{alpha}) subunits of pka |
|
79
|
264
|
3f9nA |
Crystal structure of chk1 kinase in complex with inhibitor 38 |
|
112
|
329
|
3fmdA |
Crystal structure of human haspin with an isoquinoline ligand |
|
94
|
288
|
3f7wA |
Crystal structure of putative fructosamine-3-kinase (yp_290396.1) from thermobifida fusca yx-er1 at 1.85 a resolution |
|
113
|
349
|
3fmmA |
P38 kinase crystal structure in complex with ro6226 |
